We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
7 hedge funds and large institutions have $51.4K invested in Decoy Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,459% more capital invested
Capital invested by funds: $2.01K → $51.4K (+$49.4K)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
133% more funds holding
Funds holding: 3 → 7 (+4)
0.1% more ownership
Funds ownership: 0.01% → 0.11% (+0.1%)
Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$60.5K |
| 2 |
SG
StoneX Group
New York
|
+$43.2K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$23.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.6K |
Top Sellers
| 1 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$1.83K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$130 |